Anzeige
Mehr »
Montag, 16.06.2025 - Börsentäglich über 12.000 News
Von SOL zu BTC: Pioneer aktiviert automatisierte Bitcoin-Treasury über Kora AI Beta
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
134 Leser
Artikel bewerten:
(0)

PathPresenter Showcases "Image Management Simplified" Digital Pathology Workflow at ECDP 2025

Pre-Congress Workshop, Interoperability Showcase , and Technical Session among PathPresenter's initiatives in Barcelona

MONTVILLE, NJ / ACCESS Newswire / June 4, 2025 / PathPresenter, a leading Image Management System and workflow platform developer for digital pathology, is pleased to announce it will showcase its latest advances with a number of presentations at the European Congress of Digital Pathology taking place June 25-28 in Barcelona, Spain.

  • Pre-Congress Workshop: "Image Management Simplified: PathPresenter IMS for Clinical Care, Research, Education, & AI". June 25 at 3:30pm in Room 6. Speakers:

    • Patrick Myles, CEO, PathPresenter

    • Dr. Rajendra Singh, PathPresenter co-founder and Director of Dermatopathology and Digital Pathology, Summit Health

    • Dr. Orly Ardon, Director, Digital Pathology Operations, Memorial Sloan Kettering Cancer Center

    • Dr. Anil Parwani, Chair, Department of Pathology, The Ohio State University Wexner Medical Center

    • Dr. Junya Fukuoka, Professor, Department of Pathology Informatics, Nagasaki University

  • Interoperability Showcase: "Breaking the silos and building interoperability for scalable digital pathology," June 26th at 2:30pm in the Auditorium. Speakers:

    • Dr. Rajendra Singh

    • Dr. Juan Retamero, Medical VP, Paige

    • Mirelva Drost, VP Product Management & Marketing, Barco

  • Technical Session on Generative AI: "Towards an AI Co-Pathologist," 28 June at 1pm in the Auditorium. Speaker: Dr. Rajendra Singh.

In addition to these scheduled presentations, PathPresenter will have live demos at booth #41 in the exhibit hall, including:

  • Clinical care, Research, and Education modules of our Enterprise platform

  • ConsultConnect, our innovative new web portal specifically for remote second opinions

  • Integrations of AI models from industry leading vendors.

"Exhibiting at ECDP in Barcelona is an important step for PathPresenter to expand the reach of our image management platform in Europe," said Patrick Myles, PathPresenter CEO. "We are looking forward to leveraging our domain knowledge, real-world experience, and unwavering commitment to interoperability to offer European pathologists and institutions our innovative solutions for clinical care, research, and education."

Our in-booth demonstrations will be supported by medical-grade monitors from display innovator and PathPresenter partner Barco. Don't miss the chance to see "Image Management Simplified" and speak with our staff in person at this authoritative event organized by the European Society of Digital and Integrative Pathology. To book an individual meeting or demonstration, we invite you to contact us via at www.pathpresenter.com/contact-us.

About PathPresenter

PathPresenter is an image management system and workflow platform for digital pathology. Founded by dermatopathologist and digital pathology pioneer Dr. Rajendra Singh, we are on a mission to democratize access to the world's pathology knowledge by connecting pathologists and institutions, providing a practical platform to access and use best-in-class AI models for clinical care, education, and research. Our deep domain knowledge, real world experience, and commitment to interoperability have made us the choice of tier one medical institutions as well as a thriving community of tens of thousands of users around the world. Learn more at www.pathpresenter.com.

The PathPresenter Clinical Viewer is not currently CE marked and is exempt from the requirements of Article 5 of Regulation (EU) 2017/746 (IVDR). The device is intended solely for general laboratory research use and is not intended for in vitro diagnostic purposes, clinical decision-making, or patient diagnosis. It is currently undergoing technical evaluation and conformity assessment in preparation for CE marking, but it is not yet authorized for clinical use.

Contact Details

?PathPresenter
Neil Humphrey, VP Marketing
?+1 519 498 3402
neil@pathpresenter.com

SOURCE: PathPresenter



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/pathpresenter-showcases-%22image-management-simplified%22-digital-patholo-1034580

© 2025 ACCESS Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.